Navigation Links
Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
Date:9/30/2010

EAST BRUNSWICK, N.J., Sept. 30 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the United States District Court for the Southern District of New York has dismissed the Class Action originally filed on November 25, 2008, and captioned Richard Sagall vs. Savient Pharmaceuticals, Inc., et al., against the Company and two of its former officers. The suit alleged that the Company made false and misleading statements relating to the GOUT1 and GOUT2 phase 3 clinical trials and that the Company failed to disclose in a timely manner serious adverse events which occurred in five patients in these trials. The Company and the other named defendants had filed a motion to dismiss the complaint in June 2009.

The Court's decision dismissing the Class Action is based on the plaintiff's failure to set forth particularized facts, through direct or circumstantial evidence, which give rise to a strong inference that the defendants acted with intent to defraud, recklessness or a conscious disregard of the truth. The Court also concluded that the plaintiff had not demonstrated that there was any evidence that the defendants engaged in conscious misbehavior or recklessness in the manner it disclosed the relevant clinical trials data, and that the plaintiff failed to show that the defendants had made false and misleading statements or material omissions in its statements to the detriment of the investing public. The Court's ruling, while dismissing all claims, does not preclude the plaintiff from seeking to file an amended complaint, and is also subject to appeal.

About Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(TM) (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient also manufactures and suppl
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mass. , July 28, 2015  Today, Sekisui ... A compact, affordable and efficient instrument, with a broad ... bring significant benefits to the physicians, office or hospital ... of up to 580 tests/hour with ISE, 72 patient ... and has 36 onboard assays (+3 ISE) to meet ...
(Date:7/28/2015)... ROCHESTER, N.Y. , July 28, 2015 ... of clinical trial imaging solutions, today announced that it ... the 4:00 p.m. ET market close on Tuesday, August ... chief executive officer, and Jim Groff , chief ... to discuss the company,s financial results and provide a ...
(Date:7/28/2015)... -- Zipnosis, the first virtual care solution to empower health care ... branded virtual care service line, announced an agreement with ... currently in use. ... As health systems consider how ... of providing their own branded online care for common medical ...
Breaking Medicine Technology:Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
... Express Scripts, Inc. (Nasdaq: ESRX ) announced ... operations of $290.4 million and $1,275.8 million, or $0.59 and ... detailed in Table 4 were $0.82 and $2.97 per diluted ... "Through our unwavering focus on innovation, service and ...
... 2012  Endo Pharmaceuticals Holdings (Nasdaq: ENDP ) today ... corporate overview at the Cowen & Co. 32nd Annual Heath ... ET.  The conference will be held at the Boston Marriott ... and audio archive of the presentation will be available on ...
Cached Medicine Technology:Express Scripts Reports Fourth Quarter Results 2Express Scripts Reports Fourth Quarter Results 3Express Scripts Reports Fourth Quarter Results 4Express Scripts Reports Fourth Quarter Results 5Express Scripts Reports Fourth Quarter Results 6Express Scripts Reports Fourth Quarter Results 7Express Scripts Reports Fourth Quarter Results 8Express Scripts Reports Fourth Quarter Results 9Express Scripts Reports Fourth Quarter Results 10Express Scripts Reports Fourth Quarter Results 11Express Scripts Reports Fourth Quarter Results 12
(Date:7/28/2015)... Angeles, CA (PRWEB) , ... July 28, 2015 ... ... engineer of patented products, announces Skimmer Helper, a household invention that cleans pools ... is worth $3 billion," says Scott Cooper, CEO and Creative Director of World ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... patented products, announces Shelled Out, a new household invention that makes shelling eggs ... $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director of World ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl ... as volunteers celebrate the 14th year of raising money for the Darryl Worley ... Savannah for this year’s main concert Saturday, Oct. 3. , This year’s concert ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part of ... one of the first five hospitals in the nation, to implant the newly approved ... July 23, and all are in good condition. , The CoreValve® Evolut® R System ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... that the company is in full support of National Immunization Awareness Month, which ... diseases. To stay protected against serious illnesses like the flu, measles, and pneumonia, ...
Breaking Medicine News(10 mins):Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3
... foods with oils containing alpha-linolenic acid may prevent arrhythmias, which ... studied 76,763 women who had completed a food questionnaire in ... Researchers then separated the women into five categories of ALA ... is found in a variety of leafy green vegetables, some ...
... are more likely to develop blood-related cancers when they ... hives are more likely to develop leukemia. Those who ... to develop non-Hodgkin’s lymphoma. ,Based on findings of ... to cancer because they stimulate the immune system to ...
... recent study suggest , eating fruits and vegetables won't ... ones risk for heart disease . ,For the ... exist between the foods and cancer and heart disease. ... two studies. They found total fruit and vegetable intake ...
... may be a strong link between Skin Allergies and cancer. People ... //to blood related caners as they grow older. A Swedish team ... issue of the BMC public Health. ,In this alarming ... more likely to develop Leukemia and those of us who ...
... transplantation has come a long way. The number of ... and more people lead a normal lifestyle. //However, a ... when matching donor and recipient kidneys,” gave not only ... transplant community. ,Researchers from the University ...
... young adults who have poor functioning of a key ... blockages in their arteries.// ,The researchers looked specifically ... blood vessels in the arteries, called endothelial functioning, affects ... 2,000 people were followed from childhood. Over the 21 ...
Cached Medicine News:
Patient Monitor...
... The Flu A/B ASR contains primers and a ... A and an Alexa 532-labeled probe to detect ... and a Texas Redlabeled probe for a separate ... that can detect FAM, Alexa 532 and Texas ...
... The RSV ASR contains primers and a ... Respiratory Syncytial Virus (RSV). In addition, this ... probe for a,separate sample processing control. This ... FAM and Texas Red reporter dyes such ...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: